The challenge of HIV treatment in an era of polypharmacy

D Back, C Marzolini - Journal of the International AIDS Society, 2020 - Wiley Online Library
Introduction The availability of potent antiretroviral therapy has transformed HIV infection into
a chronic disease such that people living with HIV (PLWH) have a near normal life …

Pharmacokinetics and drug–drug interactions of long-acting intramuscular cabotegravir and rilpivirine

D Hodge, DJ Back, S Gibbons, SH Khoo… - Clinical …, 2021 - Springer
Combined antiretroviral treatments have significantly improved the morbidity and mortality
related to HIV infection, thus transforming HIV infection into a chronic disease; however, the …

[HTML][HTML] US medical eligibility criteria for contraceptive use, 2024

AT Nguyen - MMWR. Recommendations and Reports, 2024 - cdc.gov
Summary The 2024 US Medical Eligibility Criteria for Contraceptive Use (US MEC)
comprises recommendations for the use of specific contraceptive methods by persons who …

[HTML][HTML] US medical eligibility criteria for contraceptive use, 2016

KM Curtis - MMWR. Recommendations and Reports, 2016 - cdc.gov
Summary The 2016 US Medical Eligibility Criteria for Contraceptive Use (US MEC)
comprises recommendations for the use of specific contraceptive methods by women and …

Long-acting HIV drugs for treatment and prevention

RM Gulick, C Flexner - Annual review of medicine, 2019 - annualreviews.org
Antiretroviral drugs have revolutionized the treatment and prevention of HIV infection;
however, adherence is critical for sustained efficacy. Current HIV treatment consists of three …

Management of drug-drug interactions between long-acting cabotegravir and rilpivirine and comedications with inducing properties: a modeling study

S Bettonte, M Berton, F Stader… - Clinical Infectious …, 2023 - academic.oup.com
Background Long-acting (LA) intramuscular cabotegravir and rilpivirine are prone to drug-
drug interactions (DDI). However, given the long dosing interval, the conduct of clinical DDIs …

Drug interactions between hormonal contraceptives and antiretrovirals

K Nanda, GS Stuart, J Robinson, AL Gray, NK Tepper… - Aids, 2017 - journals.lww.com
Objective: To summarize published evidence on drug interactions between hormonal
contraceptives and antiretrovirals. Design: Systematic review of the published literature …

Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial

KE Dooley, R Savic, A Gupte, MA Marzinke… - The Lancet …, 2020 - thelancet.com
Background Short-course preventive therapy with 12 doses of once-weekly rifapentine (900
mg) plus isoniazid (900 mg) could greatly improve tuberculosis control, especially in areas …

Achieving universal access to sexual and reproductive health services: the potential and pitfalls for contraceptive services in South Africa

N Lince-Deroche, M Pleaner, C Morroni… - South African Health …, 2016 - journals.co.za
Universal access to sexual and reproductive health services was included in the Millennium
Development Goals and has been carried forward in the new Sustainable Development …

Multipurpose prevention technologies: oral, parenteral, and vaginal dosage forms for prevention of HIV/STIs and unplanned pregnancy

IC Young, SR Benhabbour - Polymers, 2021 - mdpi.com
There is a high global prevalence of HIV, sexually transmitted infections (STIs), and
unplanned pregnancies. Current preventative daily oral dosing regimens can be ineffective …